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Neuroimaging in migraine 
To the Editor: In a recent paper published in Cephalalgia, the official 
journal of the American Headache Society, Callaghan et al.[1] reported 
on information extracted from more than 50 million headache 
visits in the USA. This indicated that as many as 9.8% of patients 
with a diagnosis of migraines underwent neuroimaging – either 
magnetic resonance angiography or computed tomography. After 
removing those patients with ‘red flags’ on neurological evaluation, the 
percentage undergoing neuroimaging decreased from 9.8% to 8.3%. 
This was contrary to the guidelines originally laid down by Frishberg,[2] 
and later confirmed in a number of studies. [3,4] These guidelines 
suggested that for migraines, there was no difference in the incidence 
of clinically meaningful pathology to the incidence in the general 
population, and that neuroimaging is unnecessary. [5] Exceptions to 
these recommendations are the presence of the following red flags:
• new-onset or change in headache in patients who are >50 years old
• thunderclap: rapid time to peak headache intensity (seconds to 
5 minutes)
• focal neurological symptoms (such as limb weakness, aura 
<5 minutes or >1 hour)
• non-focal neurological symptoms (such as cognitive disturbance)
• change in headache frequency, characteristics or associated symptoms
• abnormal findings on neurological examination
• headache that changes with posture
• headache that wakes the patient up (migraine is the most frequent 
cause of morning headache)
• headache precipitated by physical exertion or Valsalva manoeuvre 
(such as coughing, laughing and straining)
• patients with risk factors for cerebral venous sinus thrombosis
• jaw claudication or visual disturbance
• neck stiffness
• fever
• new-onset headache in a patient with a history of HIV infection
• new-onset headache in a patient with a history of cancer. 
Most headache specialists agree that neuroimaging in migraine 
is unnecessary, but in spite of this, many still continue to overuse 
neuroimaging because of the fear of litigation. All the evidence 
suggests that neuroimaging should only be used in migraine patients 
with red flags.[5]
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